Vivos Therapeutics, Inc. VVOS
0.10 USD 0.00 (+2.24%)
At closeNov 10, 2026, 7:25 AM EST
0.10 0.00 +4.18%
Pre-market · Nov 10, 7:25 AM ET
0.0937 Day range 0.097699
0.092 52-week range 2.72
- YTD
- -95.28%
- 1 year
- -96.23%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 17.44M | 15.03M | 13.80M | 16.02M | 16.89M | |
| 10.54M | 9.02M | 8.27M | 10.02M | 12.60M | |
| -19.89M | -11.17M | -17.30M | -25.03M | -20.38M | |
| -21.17M | -11.14M | -13.58M | -23.84M | -20.29M | |
| -2.07 | -2.22 | -11.14 | -25.90 | -24.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.03M | 6.26M | 1.64M | 3.52M | 24.03M | |
| 25.15M | 15.28M | 10.73M | 13.72M | 33.69M | |
| 26.70M | 7.33M | 10.32M | 8.92M | 8.15M | |
| 13.50M | 1.51M | 2.00M | 2.41M | 1.26M | |
| -1.49M | 7.95M | 411.00K | 4.80M | 25.54M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -15.26M | -12.69M | -11.95M | -19.59M | -15.73M | |
| -7.53M | -568.00K | -853.00K | -924.00K | -2.61M | |
| 18.56M | 17.88M | 10.92M | 0 | 24.17M | |
| -2.34M | -568.00K | -853.00K | -924.00K | -2.40M | |
| -4.23M | 4.62M | -1.88M | -20.51M | 5.82M |